Azora Therapeutics, Inc. (DE) SEC filings AZR
Azora Therapeutics, Inc. (DE) has 575 filings in SEC EDGAR's recent list, going back to Mar 16, 2011. Its latest annual report, Form ARS, was filed on Aug 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3/A | Amendment no. 1 to form s-3 | Oct 21, 2026 | — |
| S-3 | Shelf registration | Aug 28, 2026 | — |
| S-8 | Employee stock plan registration | Aug 28, 2026 | — |
| 424B5 | Prospectus supplement | Dec 19, 2025 | — |
| S-3 | Shelf registration | Dec 12, 2025 | — |
| S-8 | Employee stock plan registration | Sep 9, 2025 | — |
| 424B5 | Prospectus supplement | Aug 1, 2025 | — |
| 424B5 | Prospectus supplement | Jul 31, 2025 | — |
| 424B5 | Prospectus supplement | Jun 18, 2025 | — |
| S-1/A | Amended registration statement | Jun 13, 2025 | — |
| 424B3 | Prospectus | Jun 10, 2025 | — |
| S-1 | Registration statement | Jun 6, 2025 | — |
| S-3 | Shelf registration | May 30, 2025 | — |
| 424B5 | Prospectus supplement | May 2, 2025 | — |
| 424B5 | Prospectus supplement | May 2, 2025 | — |
| 424B3 | Prospectus | Dec 31, 2024 | — |
| S-1 | Registration statement | Dec 20, 2024 | — |
| S-8 | Employee stock plan registration | Dec 12, 2024 | — |
| 424B3 | Prospectus | Apr 23, 2024 | — |
| 424B5 | Prospectus supplement | Apr 18, 2024 | — |
| S-3 | Shelf registration | Apr 12, 2024 | — |
| 424B5 | Prospectus supplement | Jan 25, 2024 | — |
| S-3 | Shelf registration | Jan 12, 2024 | — |
| S-8 | Employee stock plan registration | Dec 12, 2023 | — |
| 424B3 | Prospectus | Nov 20, 2023 | — |
| S-1 | Registration statement | Nov 8, 2023 | — |
| 424B3 | Prospectus | Jul 31, 2023 | — |
| S-1/A | Amended registration statement | Jul 13, 2023 | — |
| S-1 | Registration statement | Jun 23, 2023 | — |
| 424B5 | Prospectus supplement | Feb 24, 2023 | — |
| S-8 | Employee stock plan registration | Oct 21, 2022 | — |
| POS AM | Post-effective amendment no. 4 to form s-1 | Jun 24, 2022 | — |
| POS AM | Post-effective amendment no. 3 to form f-1 | Jun 24, 2022 | — |
| 424B3 | Prospectus | Apr 12, 2022 | — |
| S-3/A | Amendment no. 1 to form s-3 | Apr 6, 2022 | — |
| S-3 | Shelf registration | Feb 25, 2022 | — |
| 424B5 | Prospectus supplement | Feb 14, 2022 | — |
| 424B3 | Prospectus | Dec 17, 2021 | — |
| S-3 | Shelf registration | Dec 6, 2021 | — |
| S-8 | Employee stock plan registration | Oct 15, 2021 | — |
| 424B3 | Prospectus | Jul 30, 2021 | — |
| S-3 | Shelf registration | Jul 20, 2021 | — |
| S-1/A | Amended registration statement | Jun 23, 2021 | — |
| 424B3 | Prospectus | Jun 14, 2021 | — |
| S-1 | Registration statement | Jun 4, 2021 | — |
| S-3 | Shelf registration | May 28, 2021 | — |
| 424B3 | Prospectus | May 28, 2021 | — |
| S-3 | Shelf registration | Apr 20, 2021 | — |
| POS AM | Post-effective amendment no. 3 to form s-1 | Apr 6, 2021 | — |
| POS AM | Post-effective amendment no. 2 to form s-1 | Apr 6, 2021 | — |
| 424B3 | Prospectus | Dec 16, 2020 | — |
| S-1 | Registration statement | Dec 4, 2020 | — |
| S-8 | Employee stock plan registration | Sep 11, 2020 | — |
| 424B3 | Prospectus | Jul 13, 2020 | — |
| S-1 | Registration statement | Jul 2, 2020 | — |
| 424B5 | Prospectus supplement | Jun 10, 2020 | — |
| 424B3 | Prospectus | May 22, 2020 | — |
| 424B3 | Prospectus | May 22, 2020 | — |
| POS AM | Post-effective amendment no. 2 to form s-1 | Apr 22, 2020 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | Apr 22, 2020 | — |
| S-3 | Shelf registration | Apr 22, 2020 | — |
| S-8 | Employee stock plan registration | Sep 13, 2019 | — |
| 424B3 | Prospectus | Apr 2, 2019 | — |
| S-1/A | Amended registration statement | Mar 29, 2019 | — |
| S-1 | Registration statement | Mar 22, 2019 | — |
| 424B4 | Prospectus | Feb 22, 2019 | — |
| S-1/A | Amended registration statement | Feb 19, 2019 | — |
| FWP | Free writing prospectus | Feb 13, 2019 | — |
| S-1 | Registration statement | Feb 12, 2019 | — |
| 424B3 | Prospectus | Nov 14, 2018 | — |
| 424B3 | Prospectus | Sep 10, 2018 | — |
| S-8 | Employee stock plan registration | Aug 16, 2018 | — |
| 424B4 | Prospectus | Jul 30, 2018 | — |
| FWP | Free writing prospectus | Jul 10, 2018 | — |
| S-1/A | Amended registration statement | Jul 10, 2018 | — |
| S-1/A | Amended registration statement | Jul 3, 2018 | — |
| S-1/A | Amended registration statement | Jun 26, 2018 | — |
| S-1/A | Amended registration statement | Jun 11, 2018 | — |
| S-1/A | Amended registration statement | Apr 16, 2018 | — |
| FWP | Free writing prospectus | Nov 27, 2017 | — |
| S-1/A | Amended registration statement | Nov 22, 2017 | — |
| FWP | Free writing prospectus | Oct 25, 2017 | — |
| S-1/A | Amended registration statement | Oct 25, 2017 | — |
| FWP | Free writing prospectus | Sep 28, 2017 | — |
| FWP | Free writing prospectus | Sep 25, 2017 | — |
| S-1/A | Amended registration statement | Sep 25, 2017 | — |
| S-1 | Registration statement | Sep 7, 2017 | — |
Showing 87 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AZR (Nasdaq), ADIL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Encino, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1513525
- Former names
- ADIAL PHARMACEUTICALS, INC. (until Oct 30, 2026); Adial Pharmaceuticals, L.L.C. (until Sep 28, 2017); ADial Pharmaceuticals, L.L.C. (until Sep 28, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.